Translations:Anti-obesity medication/22/en
Jump to navigation
Jump to search
|- |Metformin |Glucophage |Unknown |Approved for type 2 diabetes |5.6 percent |- |Cagrilintide | |Dual amylin and calcitonin receptor agonist (DACRA) |Not approved |7.8 percent |- |Cagrilintide/semaglutide |CagriSema |DACRA/GLP-1 agonist combination |Not approved |15.4 percent after 32 weeks |}